Black RS - Search Results

1

Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.

Lee M, Bard F, Johnson-Wood K, Lee C, Hu K, Griffith SG, Black RS, Schenk D, Seubert P. Lee M, et al. Among authors: black rs. Ann Neurol. 2005 Sep;58(3):430-5. doi: 10.1002/ana.20592. Ann Neurol. 2005. PMID: 16130106

2

A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.

Schenk DB, Seubert P, Grundman M, Black R. Schenk DB, et al. Neurodegener Dis. 2005;2(5):255-60. doi: 10.1159/000090365. Neurodegener Dis. 2005. PMID: 16909006 Review.

3

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; AN1792(QS-21)-201 Study. Fox NC, et al. Among authors: black rs. Neurology. 2005 May 10;64(9):1563-72. doi: 10.1212/01.WNL.0000159743.08996.99. Neurology. 2005. PMID: 15883317 Clinical Trial.

4

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F, Orgogozo JM; AN1792(QS-21)-201 Study Team. Gilman S, et al. Among authors: black rs. Neurology. 2005 May 10;64(9):1553-62. doi: 10.1212/01.WNL.0000159740.16984.3C. Neurology. 2005. PMID: 15883316 Clinical Trial.

5

Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.

Pride M, Seubert P, Grundman M, Hagen M, Eldridge J, Black RS. Pride M, et al. Among authors: black rs. Neurodegener Dis. 2008;5(3-4):194-6. doi: 10.1159/000113700. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322388 Review.

6

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M. Rinne JO, et al. Lancet Neurol. 2010 Apr;9(4):363-72. doi: 10.1016/S1474-4422(10)70043-0. Epub 2010 Feb 26. Lancet Neurol. 2010. PMID: 20189881 Clinical Trial.

7

Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.

Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative. Tosun D, et al. Brain. 2011 Apr;134(Pt 4):1077-88. doi: 10.1093/brain/awr044. Epub 2011 Mar 22. Brain. 2011. PMID: 21429865 Free PMC article.

8

Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.

Bombois S, Maurage CA, Gompel M, Deramecourt V, Mackowiak-Cordoliani MA, Black RS, Lavielle R, Delacourte A, Pasquier F. Bombois S, et al. Among authors: black rs. Arch Neurol. 2007 Apr;64(4):583-7. doi: 10.1001/archneur.64.4.583. Arch Neurol. 2007. PMID: 17420322

9

Risk factors associated with beta-amyloid(1-42) immunotherapy in preimmunization gene expression patterns of blood cells.

O'Toole M, Janszen DB, Slonim DK, Reddy PS, Ellis DK, Legault HM, Hill AA, Whitley MZ, Mounts WM, Zuberek K, Immermann FW, Black RS, Dorner AJ. O'Toole M, et al. Among authors: black rs. Arch Neurol. 2005 Oct;62(10):1531-6. doi: 10.1001/archneur.62.10.1531. Arch Neurol. 2005. PMID: 16216935 Clinical Trial.

10

A neuropsychological test battery for use in Alzheimer disease clinical trials.

Harrison J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M. Harrison J, et al. Among authors: black rs. Arch Neurol. 2007 Sep;64(9):1323-9. doi: 10.1001/archneur.64.9.1323. Arch Neurol. 2007. PMID: 17846273 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page